Gavin David Clark

Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX.

Enhance Biotech, Inc. engages in the acquisition, development and commercialization of drugs for lifestyle disorders. The company was founded on June 7, 1999 and is headquartered in New York, NY.

Vapogenix, Inc. operates as a clinical stage company which develops a new class of non-narcotic analgesics for localized pain. Its products are formulated volatile anesthetics; currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. The company was founded by Allen W. Burton, Phillip C. Phan and Danguole Spakevicius Altman in November 2007 and is headquartered in Houston, TX.

Sitka Partners Ltd. engages in growth capital investments. The company is based in LO.

Part of AstraZeneca PLC, Zeneca Garden Care is a British company that develops and manufactures pharmaceutical products, agrochemicals, and specialty chemicals. The company is based in Macclesfield, UK. Zeneca Garden Care was acquired by Zeneca Group Plc on January 01, 1995 for $84.16 million.

The Royal Society of Chemistry is an organization that supports the chemical sciences community in making the world a better place. The Royal Society of Chemistry is based in London, UK, and has subsidiaries in the United Kingdom. The British company offers various opportunities in education, inclusion, and chemistry's ability to tackle challenges. The organization aims to advance excellence, connect chemical scientists, and shape the future of the chemical sciences for the benefit of humanity. The private company has a publishing portfolio that contains over one million articles, chapters, and records from across the chemical sciences and related fields. The company also provides solutions to help businesses engage with their audience of chemical scientists.

Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom.

Founded in 1935, Glaxo Group Ltd. is a subsidiary of GSK Plc. The company is based in Middlesex, UK. At GSK, we unite science, technology and talent to get ahead of disease together.

Ashfield Healthcare GmbH engages in the provision of human resources for the marketing and sale of pharmaceutical products, including other products and services in the healthcare industry. It specializes in the preparation for product launches, accessing new target groups, and repositioning of proven products. The company was founded in 1999 and is headquartered in Hirschberg, Germany.

Purdue Pharma (Canada) manufactures and markets pharmaceutical products. It products for the treatment of pain, respiratory disease, gastrointestinal disorders, and infection control. The firm include laxatives, bronchodilators, antiseptics, and analgesics. Purdue Pharma is headquartered in Pickering, Canada

Intouch with Health Ltd. delivers IT-based patient flow management solutions to help hospitals and private healthcare providers. Its solutions include calling, wait time manager, hospital wayfinding, flow manager, patient activity manager, and performance manager. The company was founded by Rohit Sethi and Paul Blackburn in 1999 and is headquartered in Cirencester, the United Kingdom.

Oxford Spin-out Equity Management (OSEM) is wholly-owned subsidiary of University of Oxford. The firm headquartered at UK. Since 2008, OSEM is responsible for spinout companies.

Laboratoire Glaxosmithkline SAS manufactures pharmaceutical products. The company was founded in 2001 and is headquartered in Rueil-Malmaison, France.

The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020.

Orthox Ltd. develops tissue regenerative implants. The firm?s products include FibroFix Meniscus and FibroFix Cartilage. The company was founded by Nicholas James Vavasour Skaer and Oliver Kessler in 2008 and is headquartered in Abingdon, the United Kingdom.

Oxford Photovoltaics Ltd. develops and commercialize perovskite-based technology. Its technology can be coated on architectural glass to allow large buildings to generate a significant proportion of their electricity demand, effectively turning them into vertical solar farms. The firm investors include MTI partners, Longwall Venture Partners LLP, Parkwalk, University of Oxford (OSEM). The company was founded by Kevin Arthur and Henry Snaith in December 2010 and is headquartered in Kidlington, the United Kingdom.

Perspectum Ltd. provides technology solutions for diagnosing and staging liver disease. The company was founded by Rajarshi Banerjee, Stefan Karl Neubauer, Matthew David Robson, Alastair Cavanagh, James Hugh Charteris Mallinson and John Michael Brady on September 18, 2012 and is headquartered in Oxford, the United Kindgom.

Oxford Electromagnetic Solutions Ltd. designs and develops cloud-based, end-to-end smart asset management system. The firm offers OXEMS tag, Application, detector and database products. The company was founded in 2010 and is headquartered in Oxford, the United Kingdom.

HighCape Partners Management LLC (HighCape Partners) is a private equity firm founded in 2013 by Kevin Rakin and Matt Zuga. The firm headquartered in Westport, Connecticut..

Oxford Biotrans Ltd. develops and commercializes enzymatic process technologies that produce chemical compounds. The firm produces chemicals using ‘green’ biotransformation technology to starting materials into initial focus is on flavors and fragrances using its proprietary understanding of P450 enzyme catalyst technology. The company was founded by Luet Lok Wong in 2013 and is headquartered in Milton Park, the United Kingdom.

Oxstem Ltd. develops cell programming therapies. The company is headquartered in Oxford, the United Kingdom.

Oxford Investment Consultants LLP (Oxford Investment Consultants) is a venture capital firm founded in 2015 by George Edward Silvanus Robinson and Ross Hyett. The firm is headquartered in Oxford, London.

Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France.

BioAscent Discovery Ltd. provides integrated drug discovery services. The firm offers compound management and compound reformatting services. Its products include readymade screening libraries, custom screening libraries and follow-up samples. The company was founded by Sylviane Boucharens in 2013 and is headquartered in Motherwell, the United Kingdom.

Orthox Holdings Ltd. is a British biotechnology company founded in 2014. The private company is based in Abingdon, UK and engages in research and experimental development of biotechnology.

OrthoSon Ltd. engages in the development of novel medical device for the treatment of chronic low back pain. The company was founded by Constantin Coussios and is headquartered in Oxford, the United Kingdom.

Energy Revolution Ventures is a venture capital firm founded in 2021. Energy Revolution Ventures is headquartered in London, United Kingdom.

Sugarox Ltd. is based in Hertfordshire, UK. Sugarox has been selected by Innovate UK to enter its incubator program, which includes participation in the AgTech accelerator. Sugarox uses natural plant sugar-based molecules in a spray to increase the productivity, resilience, and sustainability of crop production. Sugarox Ltd. is a British company that was founded in 2018. The accelerator supports the growth of agri-tech start-ups built to solve problems and was founded by Cultivator powered by Conexus (Cultivator), Emmertech, and Economic Development Regina (EDR).

Science Creates Ventures LLP (Science Creates Ventures) is a venture capital firm founded in 2020 by Harry Destecroix and Jonathan Craton. The firm is headquartered in Bristol, United Kingdom.